当前位置:首页 - 行情中心 - 华海药业(600521) - 财务分析 - 现金流量表

华海药业

(600521)

  

流通市值:201.39亿  总市值:203.55亿
流通股本:14.67亿   总股本:14.83亿

现金流量表

报告期2023-09-302023-06-302023-03-312022-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金6,394,064,808.984,284,033,103.992,162,875,233.637,300,012,516.64
收到的税费返还191,828,510.11113,715,022.5838,883,172.41557,655,492.55
收到其他与经营活动有关的现金238,991,446.29177,626,238.1187,408,096.5264,619,817.59
经营活动现金流入的平衡项目0000
经营活动现金流入小计6,824,884,765.384,575,374,364.682,289,166,502.548,122,287,826.78
购买商品、接受劳务支付的现金1,916,874,359.31,264,085,422.7694,558,375.722,590,702,040.96
支付给职工以及为职工支付的现金1,143,862,001.56779,755,346.85439,398,311.521,334,217,634.81
支付的各项税费756,081,535.13601,113,265.64365,637,902.66764,086,061.63
支付其他与经营活动有关的现金1,556,345,428.541,039,782,934.87415,638,483.12,190,588,962.48
经营活动现金流出的平衡项目0000
经营活动现金流出小计5,373,163,324.533,684,736,970.061,915,233,0736,879,594,699.88
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额1,451,721,440.85890,637,394.62373,933,429.541,242,693,126.9
二、投资活动产生的现金流量:
收回投资收到的现金42,360,905.4947,000-50,445,695.92
取得投资收益收到的现金4,945,053.824,945,053.821,722,5003,802,117.76
处置固定资产、无形资产和其他长期资产收回的现金净额1,677,908.781,153,028.18643,345.910,718,243.11
收到的其他与投资活动有关的现金---13,400,000
投资活动现金流入的平衡项目0000
投资活动现金流入小计48,983,8687,045,0822,365,845.978,366,056.79
购建固定资产、无形资产和其他长期资产支付的现金1,255,051,190.36930,642,757.23512,853,355.682,316,284,576.56
投资支付的现金45,482,498.357,482,498.359,021,105.35157,107,738.37
支付其他与投资活动有关的现金21,472,575.496,589,575.491,595,615.1637,548,478.82
投资活动现金流出的平衡项目0000
投资活动现金流出小计1,322,006,264.2944,714,831.07523,470,076.192,510,940,793.75
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-1,273,022,396.2-937,669,749.07-521,104,230.29-2,432,574,736.96
三、筹资活动产生的现金流量:
吸收投资收到的现金---37,678,952
取得借款收到的现金2,451,500,0002,230,000,0001,430,000,0003,821,892,326.94
收到其他与筹资活动有关的现金10,000,00010,000,00010,000,00051,000,000
筹资活动现金流入平衡项目0000
筹资活动现金流入小计2,461,500,0002,240,000,0001,440,000,0003,910,571,278.94
偿还债务支付的现金2,455,429,068.731,388,882,468.73827,697,168.732,710,632,788.19
分配股利、利润或偿付利息支付的现金520,154,173.79332,223,054.8258,562,217.7318,318,664.97
其中:子公司支付给少数股东的股利、利润12,833,30012,833,300--
支付其他与筹资活动有关的现金35,424,754.1322,394,005.675,113,120.83272,577,125.73
筹资活动现金流出平衡项目0000
筹资活动现金流出小计3,011,007,996.651,743,499,529.22891,372,507.263,301,528,578.89
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额-549,507,996.65496,500,470.78548,627,492.74609,042,700.05
四、汇率变动对现金及现金等价物的影响94,725,780.63112,706,613.66-33,857,329.2354,654,378
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额-276,083,171.37562,174,729.99367,599,362.76-526,184,532.01
加:期初现金及现金等价物余额1,327,950,125.341,327,950,125.341,327,950,125.341,854,134,657.35
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额1,051,866,953.971,890,124,855.331,695,549,488.11,327,950,125.34
补充资料:
净利润-562,809,707.68-1,176,009,472.86
资产减值准备-15,230,382.16-115,971,576.19
固定资产和投资性房地产折旧-333,234,482.87-585,106,003.86
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-333,234,482.87-585,106,003.86
无形资产摊销-50,042,348.63-67,447,661.07
长期待摊费用摊销-5,304,414.57-7,083,123.49
处置固定资产、无形资产和其他长期资产的损失-25,335.85--3,590,500.13
固定资产报废损失--730,251.29-19,689,620.21
公允价值变动损失-87,028,911.45--5,201,027.43
财务费用-23,150,605.91-6,534,753.75
投资损失-20,548,000.86-75,205,045.94
递延所得税--31,299,495.61--73,703,501.07
其中:递延所得税资产减少--31,299,495.61--73,703,501.07
存货的减少--80,131,196.94--679,919,985.46
经营性应收项目的减少--109,692,518.78--818,892,795.32
经营性应付项目的增加--26,373,513.56-669,885,888.46
其他-31,942,001.29-81,610,875.86
现金的期末余额-1,890,124,855.33-1,327,950,125.34
减:现金的期初余额-1,327,950,125.34-1,854,134,657.35
公告日期2023-10-312023-08-312023-04-292023-04-29
审计意见(境内)标准无保留意见
TOP↑